Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells
Nan Xu, Xiaofei Yang, Shengli Xue, Jingwen Tan, Minghao Li, Jing Ye, Xiaoyan Lou, Zhou Yu, Liqing Kang, Zhiqiang Yan, Lei Yu, Suning Chen, Yi-Ting Wang
Topics & Concepts
RuxolitinibImmune systemT cellCytokineImmunologyCancer researchMedicineBone marrowMyelofibrosisCAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects